Showing results (2291-2300 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|April 10, 2010
A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinomaYuliang Ran, Jian Pan, Hai Hu, et al.Human Gene Therapy|April 10, 2010
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalinHitoshi Yokoyama, Katsumi Sasaki, Michael E Franks, et al.Human Gene Therapy|April 27, 2010
Critical amino acid residues within the φC31 integrase DNA-binding domain affect recombination activities in mammalian cellsRaphael Liesner, Wenli Zhang, Nadja Noske, et al.Human Gene Therapy|June 3, 2009
Stable nonviral gene transfer into primary human T cellsT Magg, S Hartrampf, M H AlbertHuman Gene Therapy|August 12, 2009
Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunityBiliang Hu, Haiguang Yang, Bingbing Dai, et al.Human Gene Therapy|May 26, 2010
Long-term type VII collagen restoration to human epidermolysis bullosa skin tissueZurab Siprashvili, Ngon T Nguyen, Maria Y Bezchinsky, et al.Human Gene Therapy|May 29, 2010
Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivoSuresh de Silva, Michael A Mastrangelo, Louis T Lotta, et al.Human Gene Therapy|June 23, 2009
Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targetingNeus Bayo-Puxan, Marta Gimenez-Alejandre, Sergio Lavilla-Alonso, et al.Human Gene Therapy|May 8, 2009
Highly efficient multicistronic lentiviral vectors with peptide 2A sequencesAbdelilah Ibrahimi, Greetje Vande Velde, Veerle Reumers, et al.Human Gene Therapy|January 1, 1990
Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case studyP Aebersold, A Kasid, S A RosenbergPageof 413